Maxer draws up documents for the marketing authorization application (MAA) of the new drugs or their indications renewal:
-
- Clinical Overview (mod. 2.5) of products for which the Marketing Authorization Application (MAA) is requested for the first time;
- Clinical Expert Statement (mod. 2.5) for the renewal process of the MAA;
- Clinical Summary (mod. 2.7)
- Clinical Study Reports
- Clinical studiers synopsis.